18 September 2020Drugs used exclusively for postmenopausal osteoporosis have not been included. Bisphosphonates have very poor oral bioavailability in fasting adults, which is decreased even further in…
9 July 2020In the main, bisphosphonates are not metabolised and are excreted unchanged in urine. Oral bisphosphonates are licensed for the primary and secondary prevention of osteoporotic…
Medicine Compliance Aid Stability
DidronelWarner Chilcott UK Ltd
Warner Chilcott UK Ltd
R2 · Red 2 Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Hygroscopic. Store in airtight containers. Complex administration regime makes it unsuitable for MCA.
29 November 2012
Lactation Safety Information
No published evidence of safety
Negligible levels anticipated in milk, due to drug’s properties, with subsequent minimal absorption from the infant’s GI tract
10 August 2020